Pharma Industry Warns EU of US Tariff Impact on Investment Shift
The European pharmaceutical industry is warning the EU Commission President Ursula von der Leyen that the Trump administration's tariffs could be the starting shot for a wave of relocation of production, research, and development from the EU to the USA.
Business